Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This study will assess the ability of naltrexone (Revia) to reduce the risk of relapse in
Alaska natives with alcohol dependence. The study will also examine whether a combination of
naltrexone and sertraline (Zoloft) yields better abstinence rates than naltrexone used alone.
Alaska Native individuals will be recruited into a 16 week outpatient study.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)